A Multicentre, Prospective, Open-label, Non-comparative Study

PHASE4UnknownINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

July 20, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

June 30, 2024

Conditions
Contraception
Interventions
DRUG

Female Contraceptive

Effimia® exerts its action by means of a gonadotropin suppression mechanism through the estrogenic and progestin action exerted by EE and NGM. The contraceptive effect of Effimia® is based on the interaction of various factors, the most important of which consist of ovulation inhibition and endometrial modifications.

Trial Locations (1)

Unknown

RECRUITING

IRCCS Ospedale Policlinico, San Martino

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Italfarmaco

INDUSTRY

NCT06067256 - A Multicentre, Prospective, Open-label, Non-comparative Study | Biotech Hunter | Biotech Hunter